Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery

Animal models for type 1 and type 2 diabetes: advantages and limitations

Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells

Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin